Is lung transplantation indicated for patients with interstitial lung disease, and what are the eligibility criteria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Lung Transplantation in Interstitial Lung Disease

Yes, lung transplantation is a critical therapeutic option for patients with advanced or progressive ILD who meet eligibility criteria, and early referral is strongly recommended to optimize outcomes. 1, 2

Indications for Lung Transplantation in ILD

Lung transplantation should be considered for patients with ILD who meet the International Society for Heart and Lung Transplantation (ISHLT) criteria, particularly those with: 3, 4

  • Age <65 years with severe functional impairment 4
  • DLCO <39% predicted 4
  • FVC decline ≥10% over 6 months 4, 5
  • Severe hypoxemia requiring high-flow oxygen 1, 2
  • 6-minute walk distance <250 meters 5
  • Progressive physiologic deterioration despite optimal medical management 4, 2

The most common ILD subtypes undergoing transplantation include idiopathic pulmonary fibrosis (IPF), which now represents the leading indication for lung transplantation worldwide, followed by fibrotic hypersensitivity pneumonitis, sarcoidosis, and connective tissue disease-associated ILD. 6, 7

Timing of Referral: Early is Critical

For patients with systemic autoimmune rheumatic disease-associated ILD (SARD-ILD), early referral for lung transplantation evaluation is conditionally recommended over waiting for further progression on optimal medical management. 1 This recommendation is particularly important because:

  • Pre-transplantation evaluation takes considerable time 1, 2
  • The need for high-flow oxygen is a marker of severity warranting immediate transfer to a transplant center 1
  • Patients with rapidly progressive ILD (RP-ILD) should receive immediate referral for transplant evaluation 2, 8
  • A 5% decline in FVC over 12 months is associated with approximately 2-fold increase in mortality, making early identification crucial 7

For patients with IPF and related fibrotic ILDs, early referral is especially critical due to the risk of acute exacerbation and accelerated development of respiratory failure. 9

Eligibility Criteria and Contraindications

Relative contraindications to lung transplantation include: 4

  • Age >60-65 years 4
  • Unstable or inadequate psychosocial profile/stability 4
  • Significant extrapulmonary disorders 4

Surgical Approach

Single lung transplantation is currently the preferred surgical procedure for fibrotic ILD, including IPF and asbestosis, according to established guidelines. 4, 10 This preference is based on:

  • Organ scarcity considerations, as bilateral transplantation uses organs that could benefit two patients 4
  • Similar survival outcomes compared to bilateral transplantation in non-suppurative ILD 10

However, bilateral lung transplantation is reserved for patients with suppurative lung disease or significant pulmonary hypertension. 10

Expected Outcomes

Post-transplant outcomes in ILD patients include: 4, 7

  • Arterial oxygen tension sufficiently improved to eliminate supplemental oxygen requirement 4
  • Lung volumes and DLCO increased 4
  • Pulmonary hypertension and right ventricular dysfunction reversed 4
  • 5-year survival approximates 50-60% after transplantation 4
  • Median survival of 5.2-6.7 years post-transplant compared to less than 2 years in advanced ILD patients who do not undergo transplant 7

Disease-Specific Considerations

Pulmonary Alveolar Proteinosis (PAP)

Lung transplantation is conditionally recommended for patients with PAP progressing despite whole lung lavage and/or pharmacological treatment who fulfill ISHLT criteria for ILD. 3 Available data from case reports demonstrate that lung transplantation reversed chronic hypoxic respiratory failure in the majority of reported cases. 3

Systemic Sclerosis-Associated ILD (SSc-ILD)

For SSc-ILD patients with progression despite first-line treatment, referral to a lung transplantation center is recommended rather than waiting for further progression. 2 Additionally, stem cell transplantation at specialized centers with proven expertise should be considered for appropriate candidates. 2

Critical Pitfalls to Avoid

  • Do not delay pulmonology referral until symptoms become severe 2
  • Do not wait for disease progression before considering lung transplantation referral in appropriate candidates 2
  • Do not manage ILD in isolation—co-management by rheumatologists and pulmonologists is essential for optimal outcomes 1, 2
  • Do not underestimate the time required for pre-transplant evaluation; early referral allows adequate time for assessment and listing 1, 2

Pre-Transplant Management

While awaiting transplantation, patients should receive: 4

  • Long-term oxygen therapy for severe hypoxemia at rest 4
  • Respiratory rehabilitation programs including exercise training, smoking cessation, and psychosocial support 4
  • Annual influenza vaccination and anti-pneumococcal vaccination 4
  • Monitoring of oxygen saturation at rest and with exertion at 3-6 month intervals 4

References

2
Guideline

Scleroderma-Associated Lung Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4
Guideline

Treatment of Asbestos-Related ILD with Lung Transplantation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

6
Research

Lung transplantation for interstitial lung disease.

European respiratory review : an official journal of the European Respiratory Society, 2021

8
Guideline

Steroid Treatment Regimens for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

9
Research

Lung Transplantation.

The Medical clinics of North America, 2019

10
Research

Lung transplantation and interstitial lung disease.

Current opinion in pulmonary medicine, 2005

Related Questions

According to guidelines, at what point should a patient with interstitial lung disease (ILD) or chronic obstructive pulmonary disease (COPD) be referred for lung transplantation?
What are the effects of smoking on the development of alveolitis (inflammation of the alveoli)?
For a middle‑aged woman with interstitial lung disease, hypertension, hiatal hernia, untreated hypothyroidism, depression, prior stroke, and a 5‑day history of cough, myalgia, rhinorrhea, baseline SpO₂ 90‑93% now 92%, and bilateral basal crackles, is it appropriate to advise her to go to the emergency department if she develops warning signs such as worsening dyspnea, SpO₂ below 88%, fever, chest pain, or altered mental status?
What inhalers (puffers) are recommended for an adult with interstitial lung disease who needs quick relief of dyspnea?
What is the prognosis and treatment for advanced Interstitial Lung Disease (ILD)?
In an adult with neck and jaw pain, tenderness over the carotid bifurcation, limited cervical motion and no red‑flag signs, should I evaluate for carotid fibromuscular dysplasia and what imaging and management are recommended?
In diabetic ketoacidosis, how should electrolytes be monitored and corrected during fluid resuscitation and insulin therapy?
What are the differences between functional iron‑deficiency anemia (IDA) and absolute iron‑deficiency anemia (IDA) in terms of pathophysiology, laboratory findings, and treatment, especially in patients with chronic inflammation, chronic kidney disease (CKD), or malignancy?
What is the target serum ferritin level for a pregnant woman and how should it be monitored and managed throughout pregnancy?
Can spironolactone be used in adults with chronic kidney disease to lower proteinuria or treat resistant hypertension, and what are the recommended dosing and monitoring parameters?
Should a patient with an inguinal hernia avoid carrying heavy loads?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.